New images from the Planck mission show previously undiscovered islands of star formation and a mysterious haze of microwave emissions in our Milky Way galaxy. The views give scientists new treasures to mine and take them closer to understanding the secrets of our galaxy.
Planck is a European Space Agency mission with significant NASA participation. (more…)
*Geologists learn how earthquakes change the landscape — down to a few inches*
Geologists have a new tool to study how earthquakes change the landscape–down to a few inches. It’s giving scientists insights into how earthquake faults behave.
In this week’s issue of the journal Science, a team of scientists from the United States, Mexico and China reports the most comprehensive before-and-after picture yet of an earthquake zone, using data from the magnitude 7.2 event that struck near Mexicali, Mexico, in April 2010. (more…)
Researchers from North Carolina State University, Sandia National Laboratories, and the University of California, San Diego have developed new technology that uses microneedles to allow doctors to detect real-time chemical changes in the body – and to continuously do so for an extended period of time.
“We’ve loaded the hollow channels within microneedles with electrochemical sensors that can be used to detect specific molecules or pH levels,” says Dr. Roger Narayan, co-author of a paper describing the research, and a professor in the joint biomedical engineering department of NC State’s College of Engineering and the University of North Carolina at Chapel Hill. (more…)
*Joint BioEnergy Institute Researchers Develop CAD-Type Tools for Engineering RNA Control Systems*
The computer assisted design (CAD) tools that made it possible to fabricate integrated circuits with millions of transistors may soon be coming to the biological sciences. Researchers at the U.S. Department of Energy (DOE)’s Joint BioEnergy Institute (JBEI) have developed CAD-type models and simulations for RNA molecules that make it possible to engineer biological components or “RNA devices” for controlling genetic expression in microbes. This holds enormous potential for microbial-based sustainable production of advanced biofuels, biodegradable plastics, therapeutic drugs and a host of other goods now derived from petrochemicals. (more…)
*A $2-million award from DOE will help bring down the cost of next-generation fuel cells.*
Fuel cells seem like an ideal energy source—they’re clean, efficient, silent and don’t require transmission lines. The hitch? They can be costly. Now scientists at Lawrence Berkeley National Laboratory (Berkeley Lab) hope to change that equation by building a sophisticated cost model that will take into account the total cost of ownership.
With a $2-million grant from the U.S. Department of Energy, a team of scientists led by Eric Masanet will perform a detailed assessment of fuel cell design and manufacturing that takes into account both intrinsic and external benefits. The aim is to quantify not only traditional manufacturing costs but also benefits that may previously have been overlooked and may ultimately bring down the cost of fuel cells. (more…)
*Spread highest in urbanized and agricultural habitats*
After its initial appearance in New York in 1999, West Nile virus spread across the United States in just a few years and is now well established throughout North and South America.
Both the mosquitoes that transmit it and the birds that are important hosts for the virus are abundant in areas that have been modified by human activities.
As a result, transmission of West Nile virus is highest in urbanized and agricultural habitats. (more…)
Researchers with UCLA’s Jonsson Comprehensive Cancer Center have developed a new screening approach to identify chemical compounds that can target and kill the stem cells responsible for creating deadly brain tumors.
Glioblastoma is one of the deadliest malignancies, typically killing patients within 12 to 18 months. These brain cancers consist of two kinds of cells: a larger, heterogeneous population of tumor cells and a smaller sub-population of stem cells, which are treatment-resistant. (more…)
Data from a clinical trial involving UCLA researchers suggest that a new therapy may potentially serve as a “functional cure” for HIV/AIDS.
The therapy, called SB-728-T, involves the modification of both copies of a patient’s CCR5 gene, which encodes the major co-receptor used by HIV to infect immune system cells.
In the Sangamo BioSciences’ phase 1 trial, SB-728-T was given to HIV patients who were on highly active antiretroviral therapy (HAART) but were considered to be “non-responders” — that is, their CD4+ T-cell levels, a key measure of immune system health, remained low. The patients’ HAART therapy was interrupted when they received the SB-728-T therapy. (more…)
